These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 16332628

  • 1. Biomarkers of human exposure to ochratoxin A.
    Scott PM.
    Food Addit Contam; 2005; 22 Suppl 1():99-107. PubMed ID: 16332628
    [Abstract] [Full Text] [Related]

  • 2. Blood, breast milk and urine: potential biomarkers of exposure and estimated daily intake of ochratoxin A: a review.
    Soto JB, Ruiz MJ, Manyes L, Juan-García A.
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016; 33(2):313-28. PubMed ID: 26565760
    [Abstract] [Full Text] [Related]

  • 3. Balkan endemic nephropathy: role of ochratoxins A through biomarkers.
    Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A.
    Mol Nutr Food Res; 2006 May; 50(6):519-29. PubMed ID: 16715544
    [Abstract] [Full Text] [Related]

  • 4. Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain.
    Coronel MB, Marin S, Tarragó M, Cano-Sancho G, Ramos AJ, Sanchis V.
    Food Chem Toxicol; 2011 Jun; 49(6):1436-42. PubMed ID: 21443919
    [Abstract] [Full Text] [Related]

  • 5. Exposure of infants to ochratoxin A with breast milk.
    Muñoz K, Blaszkewicz M, Campos V, Vega M, Degen GH.
    Arch Toxicol; 2014 Mar; 88(3):837-46. PubMed ID: 24270973
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin.
    Muñoz K, Blaszkewicz M, Degen GH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct 01; 878(27):2623-9. PubMed ID: 20031488
    [Abstract] [Full Text] [Related]

  • 7. Review. Ochratoxin A: presence in human plasma and intake estimation.
    Coronel MB, Sanchis V, Ramos AJ, Marin S.
    Food Sci Technol Int; 2010 Feb 01; 16(1):5-18. PubMed ID: 21339117
    [Abstract] [Full Text] [Related]

  • 8. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries.
    Malir F, Ostry V, Pfohl-Leszkowicz A, Roubal T.
    Biomarkers; 2012 Nov 01; 17(7):577-89. PubMed ID: 22642623
    [Abstract] [Full Text] [Related]

  • 9. Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populations.
    Manique R, Pena A, Lino CM, Moltó JC, Mañes J.
    Toxicon; 2008 Jun 01; 51(7):1281-7. PubMed ID: 18420246
    [Abstract] [Full Text] [Related]

  • 10. Human ochratoxin a biomarkers--from exposure to effect.
    Duarte SC, Pena A, Lino CM.
    Crit Rev Toxicol; 2011 Mar 01; 41(3):187-212. PubMed ID: 21401326
    [Abstract] [Full Text] [Related]

  • 11. Biomonitoring of ochratoxin A in blood plasma and exposure assessment of adult students in Bangladesh.
    Ali N, Blaszkewicz M, Manirujjaman M, Perveen R, Al Nahid A, Mahmood S, Rahman M, Hossain K, Degen GH.
    Mol Nutr Food Res; 2014 Nov 01; 58(11):2219-25. PubMed ID: 25164381
    [Abstract] [Full Text] [Related]

  • 12. Estimation of Ochratoxin A in human blood of healthy Tunisian population.
    Karima HK, Ridha G, Zied A, Chekib M, Salem M, Abderrazek H.
    Exp Toxicol Pathol; 2010 Sep 01; 62(5):539-42. PubMed ID: 19699073
    [Abstract] [Full Text] [Related]

  • 13. Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzyme-linked immunosorbent assay.
    Erkekoğlu P, Sabuncuoğlu S, Aydin S, Sahin G, Giray B.
    Toxicon; 2010 Sep 01; 55(2-3):507-13. PubMed ID: 19825387
    [Abstract] [Full Text] [Related]

  • 14. Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA.
    Zaied C, Bouaziz C, Azizi I, Bensassi F, Chour A, Bacha H, Abid S.
    Exp Toxicol Pathol; 2011 Nov 01; 63(7-8):613-8. PubMed ID: 20708395
    [Abstract] [Full Text] [Related]

  • 15. Ochratoxin A in human blood in Abidjan, Côte d'Ivoire.
    Sangare-Tigori B, Moukha S, Kouadio JH, Dano DS, Betbeder AM, Achour A, Creppy EE.
    Toxicon; 2006 Jun 15; 47(8):894-900. PubMed ID: 16626769
    [Abstract] [Full Text] [Related]

  • 16. Levels of ochratoxin A and IgG against conidia of Penicillium verrucosum in blood samples from healthy farm workers.
    Skaug MA.
    Ann Agric Environ Med; 2003 Jun 15; 10(1):73-7. PubMed ID: 12852736
    [Abstract] [Full Text] [Related]

  • 17. Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure.
    Hassen W, Abid S, Achour A, Creppy E, Bacha H.
    Toxicology; 2004 Jul 01; 199(2-3):185-93. PubMed ID: 15147792
    [Abstract] [Full Text] [Related]

  • 18. Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy.
    Abouzied MM, Horvath AD, Podlesny PM, Regina NP, Metodiev VD, Kamenova-Tozeva RM, Niagolova ND, Stein AD, Petropoulos EA, Ganev VS.
    Food Addit Contam; 2002 Aug 01; 19(8):755-64. PubMed ID: 12227939
    [Abstract] [Full Text] [Related]

  • 19. Ochratoxin A in human blood in European countries.
    Hald B.
    IARC Sci Publ; 1991 Aug 01; (115):159-64. PubMed ID: 1820330
    [Abstract] [Full Text] [Related]

  • 20. Survey of Argentinean human plasma for ochratoxin A.
    Pacin AM, Ciancio Bovier EV, Motta E, Resnik SL, Villa D, Olsen M.
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 May 01; 25(5):635-41. PubMed ID: 18473217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.